Zealand Pharma A/S (ZLDPF)
41.99
-1.12
(-2.59%)
USD |
OTCM |
Sep 24, 16:00
Zealand Pharma Research and Development Expense (Annual) : 239.48M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 239.48M |
| December 31, 2024 | 130.56M |
| December 31, 2023 | 96.68M |
| December 31, 2022 | 83.38M |
| December 31, 2021 | 89.14M |
| December 31, 2020 | 89.71M |
| December 31, 2019 | 83.48M |
| December 31, 2018 | 68.66M |
| December 31, 2017 | 48.53M |
| December 31, 2016 | 39.06M |
| December 31, 2015 | 31.08M |
| Date | Value |
|---|---|
| December 31, 2014 | 31.02M |
| December 31, 2013 | 28.26M |
| December 31, 2012 | 30.65M |
| December 31, 2011 | 22.96M |
| December 31, 2010 | 26.31M |
| December 31, 2009 | 16.73M |
| December 31, 2008 | 16.22M |
| December 31, 2007 | 18.83M |
| December 31, 2006 | 15.69M |
| December 31, 2005 | 11.48M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Genmab A/S | 1.564B |
| Ascendis Pharma A/S | 333.10M |
| Bavarian Nordic A/S | 117.03M |
| Evaxion AS | 9.691M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |